Tolremo Therapeutics logo

Tolremo Therapeutics

Tolremo Therapeutics is a cancer Resistance Prevention.

Startups icon Seedtable Score 28 Startups icon Startups

8

Funding Rounds

$81.9m

Money raised

Overview

Tolremo Therapeutics is a cancer Resistance Prevention.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Tolremo Therapeutics has raised a total of $81.9m in funding over 8 rounds.

Key Insights:

  • TOLREMO therapeutics September 2023 Series A Funding Round: $20m
  • TOLREMO therapeutics September 2023 Series A Funding Round: $20m
  • TOLREMO therapeutics June 2020 Series A Funding Round: $5.1m
  • TOLREMO therapeutics June 2020 Series A Funding Round: $5.1m
  • TOLREMO therapeutics September 2018 Series A Funding Round: $9.9m
  • TOLREMO therapeutics September 2018 Series A Funding Round: $9.9m
  • Tolremo Therapeutics Series A round, September 2018: $9.3m
  • TOLREMO therapeutics September 2017 Seed Funding Round: $2.6m
Tolremo Therapeutics logo
TOLREMO therapeutics September 2023 Series A Funding Round $20m
Tolremo Therapeutics logo
TOLREMO therapeutics September 2023 Series A Funding Round $20m
Tolremo Therapeutics logo
TOLREMO therapeutics June 2020 Series A Funding Round $5.1m
Tolremo Therapeutics logo
TOLREMO therapeutics June 2020 Series A Funding Round $5.1m
Tolremo Therapeutics logo
TOLREMO therapeutics September 2018 Series A Funding Round $9.9m
Tolremo Therapeutics logo
TOLREMO therapeutics September 2018 Series A Funding Round $9.9m
Tolremo Therapeutics logo
Tolremo Therapeutics Series A round, September 2018 $9.3m
Tolremo Therapeutics logo
TOLREMO therapeutics September 2017 Seed Funding Round $2.6m

Industries

Tolremo Therapeutics is active in the following industries: